About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists Report First Clinical Trials on Potent New Hepatitis C Drug Successfully Completed

by Kathy Jones on September 5, 2010 at 1:10 PM
Font : A-A+

 Scientists Report First Clinical Trials on Potent New Hepatitis C Drug Successfully Completed

The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed by scientists.

INX-189, which is still in the initial stages, is being considered better than current treatment drugs- ribavirin and interferon, whose side effects are often severe.

Advertisement

Professor Chris McGuigan of the Welsh School of Pharmacy, academic lead on the project, said: "The efficiency of drug release in this study has also confirmed that one single dose a day is most likely enough in treating the virus".

"We believe that INX-189 offers the possibility of more potency against Hepatitis, more rapid action in the liver, and fewer side effects than existing treatments," he added.
Advertisement

The research undertaken by Cardiff University showed INX-189 killed 90 per cent of the virus at very low (nanomolar) concentration, making it the most potent compound of its kind developed to date.

Approximately 170 million people worldwide are affected with Hepatitis C, which can lead to liver cancer, cirrhosis and death.

The research undertaken by Cardiff University showed INX-189 killed 90 per cent of the virus at very low (nanomolar) concentration, making it the most potent compound of its kind developed to date.

Source: ANI
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Scientists Report First Clinical Trials on Potent New Hepatitis C Drug Successfully Completed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests